Correlation Between Metacrine and InMed Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Metacrine and InMed Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Metacrine and InMed Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Metacrine and InMed Pharmaceuticals, you can compare the effects of market volatilities on Metacrine and InMed Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Metacrine with a short position of InMed Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Metacrine and InMed Pharmaceuticals.
Diversification Opportunities for Metacrine and InMed Pharmaceuticals
0.31 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Metacrine and InMed is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Metacrine and InMed Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on InMed Pharmaceuticals and Metacrine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Metacrine are associated (or correlated) with InMed Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of InMed Pharmaceuticals has no effect on the direction of Metacrine i.e., Metacrine and InMed Pharmaceuticals go up and down completely randomly.
Pair Corralation between Metacrine and InMed Pharmaceuticals
If you would invest 49.00 in Metacrine on August 31, 2024 and sell it today you would earn a total of 0.00 from holding Metacrine or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 1.59% |
Values | Daily Returns |
Metacrine vs. InMed Pharmaceuticals
Performance |
Timeline |
Metacrine |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
InMed Pharmaceuticals |
Metacrine and InMed Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Metacrine and InMed Pharmaceuticals
The main advantage of trading using opposite Metacrine and InMed Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Metacrine position performs unexpectedly, InMed Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in InMed Pharmaceuticals will offset losses from the drop in InMed Pharmaceuticals' long position.Metacrine vs. Protara Therapeutics | Metacrine vs. CytomX Therapeutics | Metacrine vs. Assembly Biosciences | Metacrine vs. Instil Bio |
InMed Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | InMed Pharmaceuticals vs. Allarity Therapeutics | InMed Pharmaceuticals vs. Virax Biolabs Group | InMed Pharmaceuticals vs. Biodexa Pharmaceticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |